This genetic condition causes tumors on nerve tissue. Surgery and other therapies can manage symptoms.
Update Date: 14.07.2026
Neurofibromatosis type 1 (NF1) is a genetic condition that causes changes in skin pigment and the growth of tumors on nerve tissue. Skin changes include flat, light brown spots and freckles in the armpits and groin. Tumors can grow anywhere in the nervous system, including the brain, spinal cord and nerves. NF1 is rare. About 1 in 2,500 children are born with the condition.
The tumors often are not cancerous. These are known as benign tumors. But sometimes they can become cancerous. Although symptoms often are mild, complications can occur. They may include trouble with learning, heart and blood vessel conditions, vision loss, and pain.
Treatment focuses on supporting healthy growth and development in children and managing complications in adults and children. If NF1 causes large tumors or tumors that press on a nerve, surgery can reduce symptoms. Medicines can treat tumors that grow along nerves, called plexiform neurofibromas.
Neurofibromatosis type 1 (NF1) usually is diagnosed during childhood. Symptoms are seen at birth or shortly afterward and almost always by age 10. Symptoms tend to be mild to moderate, but they can vary from person to person.
Symptoms include:
See a healthcare professional if you or your child has symptoms of neurofibromatosis type 1. The tumors are often not cancerous and are slow growing, but complications can be managed. If you or your child has a plexiform neurofibroma, a medicine is available to treat it.
Neurofibromatosis type 1 is caused by an altered gene that either is passed down by a parent or occurs at conception.
The NF1 gene is located on chromosome 17. This gene produces a protein called neurofibromin that helps regulate cell growth. When the gene is altered, it causes a loss of neurofibromin. This allows cells to multiply.
The biggest risk factor for neurofibromatosis type 1 (NF1) is a family history. For about half of people who have NF1, the disease was passed down from a parent. People who have NF1 and whose relatives aren't affected are likely to have a new change to a gene.
NF1 has an autosomal dominant inheritance pattern. This means that any child of a parent who is affected by the disease has a 50% chance of having the altered gene. However, it's possible to have NF1 without a family history of the condition.
Complications of neurofibromatosis type 1 (NF1) vary, even within the same family. Generally, complications occur when tumors affect nerve tissue or press on internal organs.
Complications of NF1 include:
To diagnose neurofibromatosis type 1 (NF1), a healthcare professional begins with a review of your personal and family medical history and a physical exam.
Your child's skin is checked for cafe au lait spots, which can help diagnose NF1.
Other tests needed to diagnose NF1 may include:
For a diagnosis of NF1, at least two symptoms of the condition must be present. A child who has only one symptom and no family history of NF1 is likely to be monitored for any other symptoms. A diagnosis of NF1 can be made by age 4.
There is no cure for neurofibromatosis type 1 (NF1), but symptoms can be managed. Generally, the sooner someone is under the care of a specialist trained in treating NF1, the better the outcome.
If your child has NF1, often yearly age-appropriate checkups are recommended to:
Adults with NF1 need screening tests that may include:
Adults who want to start a family can talk to a genetic counselor about the risks of passing the disease to a child.
Contact your healthcare team right away if you notice any changes in symptoms between visits. Many complications of NF1 can be treated effectively if therapy starts early.
Medicines have been approved by the U.S. Food and Drug Administration to treat tumors that grow in multiple nerves, known as plexiform neurofibromas. Selumetinib (Koselugo) has been approved to treat the tumors in children. Mirdametinib (Gomekli) has been approved to treat plexiform neurofibromas in both children and adults. The medicines can shrink the size of a tumor. Clinical trials of similar medicines are currently underway.
Surgery to remove tumors may be needed to treat serious symptoms or complications of NF1. Symptoms can be relieved by removing all or part of tumors that are compressing nearby tissue or damaging organs.
Cancers related to NF1 are treated with standard cancer therapies, such as surgery, chemotherapy and radiation therapy. Early diagnosis and treatment are the most important factors for a good outcome.
Researchers are testing gene therapies for neurofibromatosis type 1 (NF1). Potential new treatments could include replacing the NF1 gene to restore the function of the protein that affects cell growth, called neurofibromin.
Living with neurofibromatosis type 1 (NF1) can be challenging. But many people live healthy lives with few, if any, complications.
To help you cope:
You may be referred to a doctor who specializes in brain and nervous system conditions, known as a neurologist.
It's a good idea to be well prepared for your appointment. Here's some information to help you get ready and know what to expect.
Preparing a list of questions ahead of time can help you make the most of your time during your appointment. List your questions from most important to least important in case time runs out. For neurofibromatosis type 1, some basic questions to ask include:
In addition to the questions that you've prepared, don't hesitate to ask others that come up during your appointment.
You'll likely to be asked a number of questions. Being ready to answer them may allow time later to cover other points you want to address. Your healthcare professional may ask:
© 2026 Mayo Foundation for Medical Education and Research. All rights reserved. Terms of Use